SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-20-000827
Filing Date
2020-01-21
Accepted
2020-01-21 09:20:46
Documents
4
Period of Report
2020-01-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8k.htm 8-K 79666
2 ex2-1.htm EX-2.1 765619
3 ex2-2.htm EX-2.2 101085
4 ex99-1.htm EX-99.1 29492
  Complete submission text file 0001493152-20-000827.txt   977018
Mailing Address 1880 CENTURY PARK EAST, SUITE 1000 LOS ANGELES CA 90067
Business Address 1880 CENTURY PARK EAST, SUITE 1000 LOS ANGELES CA 90067 310-203-1000
RITTER PHARMACEUTICALS INC (Filer) CIK: 0001460702 (see all company filings)

IRS No.: 263474527 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37428 | Film No.: 20535279
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences